| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2002;22:261-265
© 2002 Elsevier Science NL
a First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland
b First Department of Cardiology, Medical University of Silesia, Katowice, Poland
c Department of Cardio-anesthesiology, Medical University of Silesia, Katowice, Poland
Received 25 November 2001; received in revised form 9 April 2002; accepted 23 April 2002.
* Corresponding author. ul. Ziolowa 47/45, 40-635 Katowice, Poland. Fax:+48-32-253000
e-mail: cisowskim{at}yahoo.com
Objective: Minimally invasive direct coronary artery bypass (MIDCAB) through the anterolateral minithoracotomy has become a promising therapeutic option in patients with lesion in left anterior descending artery (LAD), especially in multimorbid, elderly and reoperated patients with type C or B lesions. To expand the benefits of MIDCAB concept to patients with multivessel disease, a hybrid myocardial revascularization procedure (HMR) combining surgery of the LAD with interventional procedures for additional coronary lesions has recently been introduced. Methods: Between January 1999 and September 2001, 50 patients (37 male, 13 female, mean age 54.8±20.1 years) underwent an HMR procedure. MIDCAB with endoscopic left internal thoracic artery (LITA) harvesting, followed by percutaneous coronary intervention (PCI) for additional coronary lesions and percutaneous transluminal coronary angioplasty (PTCA), was performed in 11 patients (22%) and stenting in 39 patients (78%). Angiographic assessment of graft patency was performed in all patients during the PCI procedure. The clinical follow-up period was 3–32 months. Results: There were no early and late deaths. Baseline Canadian Cardiology Society (CCS) class was 2.8±0.7 versus 1.1±0.9 (P<0.001) 30 days after HMR procedure. There were no major acute in–hospital cardiac events. Angiographic studies showed patent LIMA-LAD graft in 50 patients (100%). We showed good quality of anastomosis in 49 patients (98%). There was a moderate graft stenosis in one patient (2%). At long term follow-up, the rate of major cardiac events was 12%. Five patients (10%) developed restenosis after PCI, and one patient (2%) developed significant stenosis in site of LITA-LAD anastomosis; redo PCI was performed successfully. Conclusions: The hybrid procedure is a safe and effective method for complete revascularization in selected patients with double-vessel coronary artery disease (patients with type B or C lesions in the proximal LAD). This method allows performance of complete revascularization with minimization of surgical trauma. So far, long-term results of HMR are limited by the results of PCI.
Key Words: Minimally invasive coronary artery bypass • Percutaneous transluminal coronary angioplasty • Hybrid myocardial revascularization
This article has been cited by other articles:
|
|
 |
|
  T. Kofidis, H. Gerd Paeschke, A. Lichtenberg, M. Emmert, F. Woitek, V. Didilis, A. Haverich, and U. Klima Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 49 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Byrne, M. Leacche, D. E. Vaughan, and D. X. Zhao Hybrid Cardiovascular Procedures J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 459 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jaffery, M. Kowalski, W. D. Weaver, and S. Khanal A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 691 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Vassiliades Jr, V. S. Reddy, J. D. Puskas, and R. A. Guyton Long-Term Results of the Endoscopic Atraumatic Coronary Artery Bypass Ann. Thorac. Surg., March 1, 2007; 83(3): 979 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Katz, F. Van Praet, D. de Canniere, D. Murphy, L. Siwek, U. Seshadri-Kreaden, G. Friedrich, and J. Bonatti Integrated Coronary Revascularization: Percutaneous Coronary Intervention Plus Robotic Totally Endoscopic Coronary Artery Bypass Circulation, July 4, 2006; 114(1_suppl): I-473 - I-476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Vassiliades Jr, J. S. Douglas, D. C. Morris, P. C. Block, Z. Ghazzal, S. T. Rab, and C. U. Cates Integrated coronary revascularization with drug-eluting stents: Immediate and seven-month outcome J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 956 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Boodhwani, F. D. Rubens, F. W. Sellke, T. G. Mesana, and M. Ruel Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 65 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Murphy, A. J. Bryan, and G. D. Angelini Hybrid Coronary Revascularization in the Era of Drug-Eluting Stents Ann. Thorac. Surg., November 1, 2004; 78(5): 1861 - 1867. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
